Capp Jean-Pascal
Toulouse Biotechnology Institute INSA CNRS INRAE University of Toulouse Toulouse France.
Evol Appl. 2021 Feb 19;14(4):893-901. doi: 10.1111/eva.13204. eCollection 2021 Apr.
Genetic variability, epigenetic variability, and gene expression variability (noise) are generally considered independently in their relationship with phenotypic variation. However, they appear to be intrinsically interconnected and influence it in combination. The study of the interplay between genetic and epigenetic variability has the longest history. This article rather considers the introduction of gene expression variability in its relationships with the two others and reviews for the first time experimental evidences over the four relationships connected to gene expression noise. They show how introducing this third source of variability complicates the way of thinking evolvability and the emergence of biological novelty. Finally, cancer cells are proposed to be an ideal model to decipher the dynamic interplay between genetic, epigenetic, and gene expression variability when one of them is either experimentally increased or therapeutically targeted. This interplay is also discussed in an evolutionary perspective in the context of cancer cell drug resistance.
遗传变异性、表观遗传变异性和基因表达变异性(噪音)在与表型变异的关系中通常被独立考虑。然而,它们似乎本质上是相互关联的,并共同对表型变异产生影响。遗传和表观遗传变异性之间相互作用的研究历史最为悠久。本文则探讨了基因表达变异性与其他两者关系的引入,并首次综述了与基因表达噪音相关的四种关系的实验证据。这些证据表明,引入这第三种变异性来源会使关于进化能力和生物新奇性出现的思考方式变得复杂。最后,当其中一种变异性通过实验增加或进行治疗靶向时,癌细胞被认为是解读遗传、表观遗传和基因表达变异性之间动态相互作用的理想模型。在癌细胞耐药性的背景下,还从进化的角度讨论了这种相互作用。